- Home
- INDP vs JVA Comparison
INDP vs JVA Comparison
Compare INDP & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- JVA
- Stock Information
- Founded
- INDP 2000
- JVA 1971
- Country
- INDP United States
- JVA United States
- Employees
- INDP N/A
- JVA N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- JVA Packaged Foods
- Sector
- INDP Health Care
- JVA Consumer Staples
- Exchange
- INDP Nasdaq
- JVA Nasdaq
- Market Cap
- INDP 10.2M
- JVA N/A
- IPO Year
- INDP N/A
- JVA 2005
- Fundamental
- Price
- INDP $0.94
- JVA $3.68
- Analyst Decision
- INDP Strong Buy
- JVA
- Analyst Count
- INDP 2
- JVA 0
- Target Price
- INDP $8.50
- JVA N/A
- AVG Volume (30 Days)
- INDP 25.7K
- JVA 162.6K
- Earning Date
- INDP 11-12-2024
- JVA 02-07-2025
- Dividend Yield
- INDP N/A
- JVA N/A
- EPS Growth
- INDP N/A
- JVA N/A
- EPS
- INDP N/A
- JVA 0.20
- Revenue
- INDP N/A
- JVA $76,111,698.00
- Revenue This Year
- INDP N/A
- JVA N/A
- Revenue Next Year
- INDP N/A
- JVA N/A
- P/E Ratio
- INDP N/A
- JVA $18.10
- Revenue Growth
- INDP N/A
- JVA 17.27
- 52 Week Low
- INDP $0.84
- JVA $0.81
- 52 Week High
- INDP $3.10
- JVA $4.66
- Technical
- Relative Strength Index (RSI)
- INDP 40.51
- JVA 47.99
- Support Level
- INDP $0.94
- JVA $3.92
- Resistance Level
- INDP $1.01
- JVA $4.66
- Average True Range (ATR)
- INDP 0.06
- JVA 0.40
- MACD
- INDP 0.00
- JVA -0.07
- Stochastic Oscillator
- INDP 28.24
- JVA 22.22
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.